Outcome of Conventional IVF and ICSI on Sibling Oocytes in Moderate Ligoasthenozoospermia
Overview
Authors
Affiliations
Objective: To evaluate the outcomes of patients with moderate oligoasthenozoospermia treated with conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
Methods: A total of 99 couples with moderate oligoasthenozoospermia undergoing their first IVF/ICSI cycle were included in the study. Sibling oocytes were randomized to be inseminated either by conventional IVF or ICSI. Fertilization rate, cleavage rate, embryo quality, implantation rate, and clinical pregnancy rate were examined.
Results: There was no difference in the fertilization rate, cleavage rate, implantation rate, and pregnancy rate between conventional IVF and ICSI (P>0.05). The good quality embryo rate was significant difference between after IVF and after ICSI (P<0.05).
Conclusions: Couples with moderate oligoasthenozoospermia did not influence the major indices of IVF and the uncertainties concerning the safety of ICSI, couples with moderate oligoasthenozoospermia need not be subjected to ICSI.
Emirdar V, Acet F Pak J Med Sci. 2023; 39(3):672-676.
PMID: 37250564 PMC: 10214791. DOI: 10.12669/pjms.39.3.7003.
Chamayou S, Giacone F, Cannarella R, Guglielmino A J Clin Med. 2023; 12(2).
PMID: 36675600 PMC: 9867417. DOI: 10.3390/jcm12020671.
Considerations on staffing levels for a modern assisted reproductive laboratory.
Sciorio R, Aiello R, Janssens R JBRA Assist Reprod. 2022; 27(1):120-130.
PMID: 36515254 PMC: 10065777. DOI: 10.5935/1518-0557.20220048.
Chamayou S, Ragolia C, Alecci C, Storaci G, Romano S, Sapienza R Reprod Biol Endocrinol. 2021; 19(1):116.
PMID: 34311751 PMC: 8311920. DOI: 10.1186/s12958-021-00804-2.
Zheng D, Zeng L, Yang R, Lian Y, Zhu Y, Liang X BMJ Open. 2019; 9(9):e030366.
PMID: 31575574 PMC: 6773417. DOI: 10.1136/bmjopen-2019-030366.